Literature DB >> 1422325

Radioiodine for hyperthyroidism.

J Franklyn, M Sheppard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1422325      PMCID： PMC1883395          DOI： 10.1136/bmj.305.6856.727

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.

Authors:  S D Sarkar; W H Beierwaltes; S P Gill; B J Cowley
Journal:  J Nucl Med       Date:  1976-06       Impact factor: 10.057

2.  Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study.

Authors:  B M Dobyns; G E Sheline; J B Workman; E A Tompkins; W M McConahey; D V Becker
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

3.  Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism.

Authors:  A M Safa; O P Schumacher; A Rodriguez-Antunez
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

4.  The spectrum of thyroid disease in a community: the Whickham survey.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

5.  Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism.

Authors:  J S Robertson; C A Gorman
Journal:  J Nucl Med       Date:  1976-09       Impact factor: 10.057

6.  Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy.

Authors:  S S Stoffer; J I Hamburger
Journal:  J Nucl Med       Date:  1976-02       Impact factor: 10.057

7.  Leukaemia incidence after iodine-131 exposure.

Authors:  P Hall; J D Boice; G Berg; G Bjelkengren; U B Ericsson; A Hallquist; M Lidberg; G Lundell; A Mattsson; J Tennvall
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

8.  Thyroid carcinoma after radioiodide therapy for hyperthyroidism. Analysis based on age, latency, and administered dose of I-131.

Authors:  R P Spencer; C N Chapman; H Rao
Journal:  Clin Nucl Med       Date:  1983-05       Impact factor: 7.794

9.  Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

Authors:  K Hashizume; K Ichikawa; A Sakurai; S Suzuki; T Takeda; M Kobayashi; T Miyamoto; M Arai; T Nagasawa
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Treatment of Graves' disease and the course of ophthalmopathy.

Authors:  V Sridama; L J DeGroot
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965
View more
  5 in total

1.  Radioiodine for hyperthyroidism.

Authors:  M H Wheeler
Journal:  BMJ       Date:  1992-11-07

2.  Radioiodine for hyperthyroidism.

Authors:  D O'Halloran; S M Shalet
Journal:  BMJ       Date:  1992-11-07

3.  Safety and efficacy of surgical management of hyperthyroidism: 15-year experience from a tertiary care center in a developing country.

Authors:  P V Pradeep; Amit Agarwal; Mukta Baxi; Gaurav Agarwal; Sushil Kumar Gupta; S K Mishra
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.

Authors:  H I Adamali; J Gibney; D O'Shea; M Casey; T J McKenna
Journal:  Ir J Med Sci       Date:  2007-07-14       Impact factor: 1.568

5.  Hyperthyroidism and radio-iodine therapy in a district general hospital.

Authors:  D F Child; M A Mughni; P Hudson; C P Williams; J N Harvey
Journal:  J R Soc Med       Date:  1994-10       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.